These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1749 related articles for article (PubMed ID: 26241750)

  • 1. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
    Batrakova EV; Kim MS
    J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: cell-created drug delivery systems.
    Familtseva A; Jeremic N; Tyagi SC
    Mol Cell Biochem; 2019 Sep; 459(1-2):1-6. PubMed ID: 31073888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
    Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
    J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
    Ferguson SW; Nguyen J
    J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome: a significant nano-scale drug delivery carrier.
    Peng H; Ji W; Zhao R; Yang J; Lu Z; Li Y; Zhang X
    J Mater Chem B; 2020 Sep; 8(34):7591-7608. PubMed ID: 32697267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
    Ke W; Afonin KA
    Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two endogenous delivery agents in cancer therapy: Exosomes and ferritin.
    Li L; Zhang L; Knez M
    Pharmacol Res; 2016 Aug; 110():1-9. PubMed ID: 27157249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy.
    Bu H; He D; He X; Wang K
    Chembiochem; 2019 Feb; 20(4):451-461. PubMed ID: 30371016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Protein Engineering and Bioorthogonal Click Conjugation for Extracellular Vesicle Modulation and Intracellular Delivery.
    Wang M; Altinoglu S; Takeda YS; Xu Q
    PLoS One; 2015; 10(11):e0141860. PubMed ID: 26529317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design strategies and application progress of therapeutic exosomes.
    Liu C; Su C
    Theranostics; 2019; 9(4):1015-1028. PubMed ID: 30867813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
    Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.